Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Rosavin is a primary active compound found in Rhodiola rosea, an adaptogenic herb traditionally used in Russia and Scandinavia to combat fatigue and support mental performance. Over the last two decades, a number of preclinical and clinical studies have explored the potential antidepressant effects of Rhodiola rosea extracts standardized to contain rosavin and related compounds. Several small-scale randomized controlled trials and open-label studies suggest that Rhodiola rosea may modestly alleviate symptoms of mild to moderate depression, possibly through mechanisms involving modulation of neurotransmitters such as serotonin, norepinephrine, and dopamine, as well as reduction of cortisol levels and oxidative stress. However, the majority of these studies used whole plant extracts rather than isolated rosavin, making it difficult to attribute effects specifically to rosavin itself. The quality of evidence is generally limited by small sample sizes, short durations, and methodological weaknesses. Meta-analyses and systematic reviews conclude that while there is preliminary support for Rhodiola rosea (and by extension, rosavin-containing extracts) in supporting mood and reducing depressive symptoms, the evidence is insufficient to recommend it as a first-line treatment for depression. Larger, high-quality clinical trials are needed to clarify its efficacy and safety profile, and to determine the specific role of rosavin versus other constituents.

More about Rosabin
More about Depression

Other ingredients used for Depression

Other health conditions supported by Rosabin

Products containing Rosabin